Depletion of ORC6 using specific shRNA or Cas9-sgRNA KO significantly reduced cell viability and proliferation while disrupting cell cycle progression and mobility, eventually inducing apoptosis in primary and immortalized (A172) glioma cells. This evidence concerns the gene ORC6 and central nervous system cancer.